StonvexLoading…
StonvexStonvexStonvexCore line items from STG's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $288.84M | $272.66M | $304.17M | $336.82M |
Operating Income | $53.84M | $40.81M | $80.97M | $89.45M |
Net Income | $52.28M | $46.87M | $90.26M | $93.37M |
EPS (Diluted) | $7.76 | $6.87 | $13.08 | $13.65 |
Total Assets | $292.75M | $290.60M | $298.38M | $330.00M |
Total Liabilities | $157.75M | $208.42M | $259.57M | $385.07M |
Cash & Equivalents | $82.33M | $69.49M | $107.58M | $109.27M |
Free Cash Flow OCF − CapEx | $20.96M | $26.75M | $19.02M | $859.00K |
Shares Outstanding | 6.74M | 6.82M | 6.90M | 6.84M |